Pharmaceuticals, Biotechnology and Life Sciences
Group Aims to Bring Disease-Associated Biomarker Through FDA’s Drug Development Tools Qualification Program LOUISVILLE, Ky.–(BUSINESS WIRE)–The ERP Biomarker Qualification Consortium…
CAMBRIDGE, England–(BUSINESS WIRE)–The Mundipharma network of independent associated companies is pleased to launch the type-2 diabetes mellitus (T2DM) treatments Invokana®…
CRO now recruiting for biostats, data management and other positions RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CRO?src=hash” target=”_blank”gt;#CROlt;/agt;–Representatives from Synteract, an…
DUBLIN–(BUSINESS WIRE)–The “Innovations in Industrial Bioprocessing” report has been added to ResearchAndMarkets.com’s offering. This edition of the Industrial Bio processing…
DUBLIN–(BUSINESS WIRE)–The “Diabetes Drug Intelligence Center (2012-2023)” report has been added to ResearchAndMarkets.com’s offering. The Diabetes Drug Intelligence Center (IC)…
DUBLIN–(BUSINESS WIRE)–The “Innovations in Stem Cells, Cellular Therapies, Diabetes Therapy, Gene Therapies, Antiaging Research, Biomarkers, and Vaccines” report has been…
DUBLIN–(BUSINESS WIRE)–The “Mergers and Acquisitions in the Global Life Sciences Industry, 2018” report has been added to ResearchAndMarkets.com’s offering. The…
Novartis’ eye care division Alcon has bought a privately-held US medical device company PowerVision, which focuses on focused on creating fluid-based intraocular lens implants, for $285 million at closing with additional payments based on specified regulatory and commercial milestones starting in 2023.
Amarin Corporation’s Vascepa provided a statistically significant 30% risk reduction in total (first and subsequent) cardiovascular events compared to placebo in the statin-treated patient population studied in REDUCE-IT, as presented in a cardiovascular outcomes study.
Allergan has expanded the label of Avycaz, as it got approval from the US FDA for its supplemental New Drug Application (sNDA), for treating young patients with complicated intra-abdominal infections.